Centerpoint Energy Inc
$48.38B- Market cap
- $25.95B
- Debt
- +$22.98B
- Cash
- −$548.00M
Capital structure 53% equity / 47% debt · EV / Revenue 5.17x · EV / EBITDA 19.33x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CNP stock price at discount vs SUPN $39.67 current versus $50.34 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SUPN's multiple
Implied fair value · at CNP's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CNP FY 2025 (ended Dec 31, 2025) · SUPN FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 53% equity / 47% debt · EV / Revenue 5.17x · EV / EBITDA 19.33x
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
CNP carries the larger enterprise value at $48.38B against $2.45B; SUPN trades on the lower EV / Revenue multiple (3.40x vs 5.17x); CNP on the lower EV / EBITDA (19.33x vs 50.52x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CENTERPOINT ENERGY INC · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
SUPERNUS PHARMACEUTICALS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.06x
0.04x
Net debt / EBITDA
Leverage against operating earnings
8.96x
-1.75x
Cash and equivalents
Liquid reserves on the balance sheet
$548.00M
$128.45M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEXTERA ENERGY INC
CNP vs NEE
DOMINION ENERGY, INC
CNP vs D
SOUTHERN CO
CNP vs SO
CONSOLIDATED EDISON INC
CNP vs ED
Jazz Pharmaceuticals plc
CNP vs JAZZ
INCYTE CORP
CNP vs INCY
ANI PHARMACEUTICALS INC
CNP vs ANIP
Vanda Pharmaceuticals Inc.
CNP vs VNDA
Harmony Biosciences Holdings, Inc.
CNP vs HRMY
$22.98B
$43.80M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.